Medication info
Arigrel Capsule

Arigrel Capsule

Prescription medicationHard capsule
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 capsuleAspirin Enteric Pellets›122mg / 1 capsule
Manufacturer / importer
Huons Co., Ltd.
Appearance
A hard capsule with an upper and lower orange shell containing white or yellowish granules and enteric-coated pellets.
Packaging
30 capsules/bottle, 300 capsules/bottle
Approval status
Active

MFDS item code 201200636 · Approved 2012.01.31

Summary

Main use
Improvement of atherosclerotic symptoms in acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who uses it
Adults
Adult dosage
Administer 1 capsule once daily.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Improvement of atherosclerotic symptoms in acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Acute coronary syndrome
  • unstable angina
  • non-ST elevation myocardial infarction
  • atherosclerotic symptoms
  • cardiovascular anomalies
  • myocardial infarction
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
  • atherothrombosis
View approved original text

This medicine is used for certain patients who require the combined administration of clopidogrel and aspirin. It helps improve cardiovascular issues such as death, myocardial infarction, stroke, or ischemic conditions in patients with acute coronary syndrome, including unstable angina or non-ST elevation myocardial infarction, who have received drug treatment or coronary interventions or are scheduled for coronary bypass surgery. Additionally, it is used in patients with atrial fibrillation who have vascular risk factors to reduce the risk of stroke and thrombosis when the risk of bleeding is low and vitamin K antagonists are not suitable. This medication is effective for the prevention of cardiovascular complications and the reduction of stroke risk.

Dosage and Administration

Adult dosage

Administer 1 capsule once daily.

Precautions

This medication is intended to prevent blood clot formation by inhibiting coagulation. However, bleeding may take longer to stop after taking this medication, so you should inform your healthcare provider immediately if bleeding does not stop or lasts abnormally long. You must inform your healthcare team that you are taking this medication before undergoing surgery or starting new medications. Moreover, individuals with genetically reduced function of a specific enzyme (CYP2C19) may experience reduced effectiveness of this medication, increasing the risk of recurrence of cardiovascular diseases. Taking this medication in conjunction with other drugs that affect enzyme function may increase bleeding risks and should be approached with caution. Frequent alcohol consumption may increase the risk of gastrointestinal bleeding while taking this medication, so consultation with a doctor or pharmacist is essential. This medication should not be used by individuals with specific diseases or allergies to certain medications, severe liver or kidney dysfunction, or during late pregnancy or breastfeeding. Patients with a history of gastrointestinal bleeding or blood disorders, bleeding tendencies, or patients with acute stroke should use this medication cautiously and stop taking it 5 to 7 days prior to scheduled surgery. This medication may increase bleeding risks, so extra caution is advised when using it alongside other drugs that also increase bleeding risks, and you should consult healthcare professionals immediately if unusual symptoms arise. During treatment, you should monitor for gastrointestinal symptoms (abdominal pain, heartburn, nausea, etc.), skin rash, allergy symptoms, and signs of bleeding. In the early or mid-stages of pregnancy, it should be administered at the discretion of a physician and should not be administered in late pregnancy. It should not be used during breastfeeding. The safety and efficacy of this medication in children and adolescents under 18 years old have not been established, hence it is not recommended. In cases of overdose, the risk of bleeding may increase, so dosage must be strictly adhered to, and any unusual symptoms should be reported to healthcare professionals immediately. This medication should be stored at room temperature and kept out of reach of children. While this medication is not known to have a significant impact on driving or operating machinery, this may vary by individual, so caution is advised.

Side effects

Hemorrhage, gastrointestinal bleeding, hospitalization-required hemorrhage, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, hemorrhagic stroke, thrombocytopenia, neutropenia, agranulocytosis, aplastic anemia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, shock, anaphylactic symptoms, fixed rash, drug reaction with eosinophilia and systemic symptoms, Liel syndrome, Stevens-Johnson syndrome, exfoliative dermatitis, pancytopenia, double blood cell reduction, bone marrow insufficiency, impaired platelet function, anorexia, heartburn, gastric pain, vomiting, tinnitus, hearing loss, vertigo, excitement, elevated liver enzymes, liver damage, chronic hepatitis, renal impairment, acute renal failure, hyperventilation, metabolic acidosis, confusion, hallucination, dysgeusia, ageusia, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, maculopapular rash, erythematous eruption, urticaria, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulonephritis, gynecomastia, fever, abnormal liver function tests, increased serum creatinine, anorexia, weight loss, visual disturbances, dizziness, weight gain, facial flushing, reduced exercise capacity, polydipsia, memory loss, impaired cognition, pollakiuria, arrhythmia, tremor, speech impairment, abnormal gait, hyperactivity, ataxia, hiccups, dysphagia, tongue disorder, abnormal behavior, rigidity, visual disturbance, dry eyes, temporary blindness, congestion, urination disorders, uremia, hypoglycemia, bradycardia, tinnitus, contact dermatitis, elevated PSA

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a sealed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps preserve the drug’s effectiveness and safety over time.

Appearance and packaging

Appearance

A hard capsule with an upper and lower orange shell containing white or yellowish granules and enteric-coated pellets.

Package unit

30 capsules/bottle, 300 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.